Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 103 of 123)
- Relevance
  Sort by

Autoimmune Diseases Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
116 Pages
Global

From

€4090EUR$4,500USD£3,473GBP

Orphan Drugs Market Report by Drug Type, Disease Type, Phase, Top Selling Drugs, Distribution Channel, and Region 2025-2033

 Report
February 2025
148 Pages
Global

From

€2726EUR$2,999USD£2,315GBP

Nasopharyngeal Cancer Market Report: Trends, Forecast and Competitive Analysis to 2030

 Report
September 2024
150 Pages
Global

From

€4408EUR$4,850USD£3,743GBP

Sandhoff Disease Market Report and Forecast 2024-2032

 Report
February 2024
180 Pages
Global

From

€4517EUR$4,969USD£3,835GBP

Protein Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2024
89 Pages
Global

From

€3500EUR$4,125USD£3,076GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Gastrointestinal Stromal Tumors - Pipeline Insight, 2025

 Report
April 2025
85 Pages
Global

From

€1818EUR$2,000USD£1,544GBP

Malignant Pleural Mesothelioma- Pipeline Insight, 2025

 Report
April 2025
60 Pages
Global

From

€1818EUR$2,000USD£1,544GBP

Ulcerative Colitis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
August 2022
115 Pages
Global

From

€4317EUR$4,750USD£3,666GBP

Global Cell & Gene Therapy Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update

 Report
August 2023
1350 Pages
Global

From

€5663EUR$6,230USD£4,809GBP

€8090EUR$8,900USD£6,869GBP

Rheumatic Fever Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
117 Pages
Global

From

€3500EUR$4,125USD£3,076GBP

Ischemic Optic Neuropathy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
December 2023
223 Pages
Global

€4540EUR$4,995USD£3,855GBP

Esophageal Cancer - Market Insight, Epidemiology and Market Forecast - 2034

 Report
February 2024
245 Pages
Global

From

€7226EUR$7,950USD£6,136GBP

Oncolytic Virus Cancer Therapy - Pipeline Insight, 2025

 Report
April 2025
280 Pages
Global

From

€4545EUR$5,000USD£3,859GBP

Oncology Drugs Global Market Opportunities and Strategies to 2032

 Report
April 2023
501 Pages
Global

From

€3181EUR$3,500USD£2,701GBP

€4545EUR$5,000USD£3,859GBP

Chimeric Antigen Receptor T (CAR-T) Cells Global Market Report 2023

 Report
April 2023
200 Pages
Global

From

€4545EUR$5,000USD£3,859GBP

CCR Inhibitor - Pipeline Insight, 2025

 Report
April 2025
120 Pages
Global

From

€1818EUR$2,000USD£1,544GBP

Idiopathic Pulmonary Fibrosis Market by Drug Type and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030

 Report
January 2022
169 Pages
Global

From

€2362EUR$2,598USD£2,006GBP

€3374EUR$3,712USD£2,865GBP

Ischemic Cerebral Stroke Prevention Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
November 2024
86 Pages
Global

From

€3500EUR$4,125USD£3,076GBP

Europe Soft Tissue Sarcoma Market By Treatment (Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drug, Radiation Therapy), By Disease Type, By End User, By Country, Competition, Forecast & Opportunities, 2028

 Report
April 2023
86 Pages
Europe

From

€3636EUR$4,000USD£3,087GBP

Orphan Drugs Market Analysis & Forecast 2024-2034: Market By Drug Type; By Therapy; By Distribution Channel; and By Region

 Report
October 2023
145 Pages
Global

From

€2863EUR$3,150USD£2,431GBP

2,452 Results (Page 103 of 123)
- 1
- 101
- 102
- 103
- 104
- 105

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.